APR 06, 2016 06:27 AM PDT

Hydrogel Bubble Mimics a Tumor Microcosm

WRITTEN BY: Xuan Pham
Tumor hydrogel bubble provides testing ground for anticancer drugs
Using a gelatin-based hydrogel mix, scientists from Queensland University of Technology (QUT) can model a cancer microenvironment in a small gel bubble. These tiny ‘gems’ can be infused with different tumor cells to model patient-specific tumors. Moreover, this tumor microcosm can be the testing ground for anticancer drugs, which could enable personalized therapy and cut down the time a selected treatment takes effect in the patient.
 
Key to this technique is the process of making the hydrogel bubbles. "Hydrogel is a biomaterial used by thousands of researchers around the globe; gelatine is based on collagen, one of the most common tissues in the human body. We have modified the gelatine to engineer 3D tumour microenvironments," said Dietmar Hutmacher, Professor at QUT and senior study author.
 
 

Though the substance is not new, the team found innovative ways to manufacture the hydrogel on a large scale while keeping costs low. To the hopeful researchers, this means widespread use of such system to model cancer in reproducible and meaningful ways. "It is highly reproducible which means we have been able to produce this hydrogel hundreds of times, not just once or twice in the lab, so researchers worldwide will be able to create it," said Hutmacher. The hydrogel can also be modified to replicate the density of different tissues, including firm cartilage or soft breast tissues.
 
Once infused with patient-derived tumor cells, the hydrogel bubble becomes a live, 3-dimensional model of cancer growth. Unlike mouse ‘avatars’ or other animal model of cancer, the hydrogel model is cheaper and faster to produce. As such, the team proposes that more anticancer therapies can be tested on these 3D constructs, which will better inform clinicians on the treatments for their patients.
 
"Instead of the sometimes hit and miss chemotherapy that affects every cell in the body this will allow us to test different anti-cancer drugs and different combinations of them all at once so that we can pinpoint an individualized treatment that will hit only the cancer cells,” said Hutmacher.
 
He estimates that the hydrogel model will “cut the process of finding a personalized treatment for each patient down to a week or two." Optimistic as he may be, they have yet to report on results from animal studies, which are needed to confirm the utility of their proposed constructs. 

Additional source: QUT press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
NOV 14, 2018
Immunology
NOV 14, 2018
Reversing T Cell dysfunction in Cancer: Getting the Body to Fight its own Battles
Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy,...
DEC 05, 2018
Immunology
DEC 05, 2018
Combo-Kick to Battle Lymphoma
Combination immunotherapy has provided remission for patients suffering from Hodgkin's Lymphoma...
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
Loading Comments...